bodyType

customContents

entityId

entityUuid

articlePageQuery

filter

article

articleBaseAdvertisingInfoArticle

articleListArticle

articleSeoArticle

helpersCheckIsPostiesArticle

hooksArticleAcknowledgementGateOverlayArticle

hooksTrackPageViewArticle

hooksContentInterestArticle

articleLinkingDataContent

articleSchemaContent

liveArticle

advertZone

sentiment

contentLock

topics

types

sections

moreOnThisArticles

urlAlias

commentCount

authorLocations

authors

paywallTypes

corrections

sponsorType

displaySlideShow

multimediaEmbed

printHeadline

seriesContainer

socialHeadline

headline

flag

firstTopic

glossary

flattenTypeIds

publishedDate

additionalInfoBoxes

images

image

relatedLinks

relatedNewsletters

__typename

createdDate

sponsor

factSheets

seriesReverseOrder

series

disableOffPlatformContent

published

updatedDate

summary

subHeadline

body

keywords

copyrighted

customTimezone

liveContents

Ben Westcott

Zhuang Pinghui

A Chinese medical team’s attempt to genetically alter human embryos to make them resistant to HIV has raised questions in the medical community over the ethics of the experiment.
In only the second paper ever published on genetic editing in human embryos, a team from Guangzhou Medical University described their attempt to mutate a gene found to hinder the spread of HIV in humans.
China, US race to develop ‘gene editing’ technology that could, if approved, revolutionise medicine
The Guangzhou Medical University’s paper, published in the Journal of Assisted Reproduction and Genetics on April 6, described how scientists used the genetic-editing CRISPR-Cas technology to experiment on 213 embryos. These fertilised eggs, donated after being found out unsuitable for implantation as part of in-vitro fertility therapy for containing an extra set of chromosomes, were destroyed three days later.
Only four embryos were successfully modified, with the rest still containing the original genes or unexpected mutations.

It comes almost a year after another Chinese medical team published the first paper on editing in genes linked with a potentially fatal blood disorder in a human embryo, igniting a fierce debate among scientists.
Chinese scientists genetically modify human embryos for the first time
One of the researchers, Fan Yong, said through a statement from his university that his research was approved by an ethics committee and that all the donors consented. The research was only to test the feasibility and laying rules for sequencing the genomes of early state human embryos for future treatment of genetic diseases.
“We advocate preventing any application of genome editing on the human germline until after a rigorous and thorough evaluation and discussion are undertaken by the global research and ethics communities,” Fan said in the published paper.
The scientific community has long been divided over the subject of genetic modification of human embryos. One objection is the possibility of unintended consequences occurring in future generations, and another is that the technology could lead to the creation of “designer” babies created for the wealthy.
In February, however, researchers at the Francis Crick Institute in London were given approval to use the genome-editing technique CRISPR/Cas9 in healthy human embryos to develop treatments for infertility.

Associate Professor Robert Sparrow of the Monash University Centre for Human Bioethics in Melbourne, said the experiment could help to refine the gene-editing process in humans, but may not lead to a long-term solution to HIV.
The DNA dilemma: Opposition mounts to genetic modification of human embryos
“They’ve used something where you can think of it as a therapeutic project to test the technology, which could then be used to put any genes into human embryos,” he said.
“It’s most plausible use, and most likely use, is the technology of human enhancement.”
Sparrow said as the technique wasmore likely to be an early test for future genetic enhancement in humans.
If you were serious about not wanting to go down this path ... then the time to try and stop it is now
Professor Robert Sparrow, Monash University
“If you were serious about not wanting to go down this path where wealthy people are having children who have been genetically modified to have capacities that aren’t available to the children of poor parents, then the time to try and stop it is now,” Sparrow said.
“Once someone shows they can do it safely and effectively and then we try to say ‘no, we shouldn’t do it’, that strikes me as too late.”
An expert in molecular embryonic development at the Chinese Academy of Sciences said the novelty of the paper, published in an obscure journal, was that it tested the theory and technology on human embryos, but neither the theory nor the technology were groundbreaking.
He said there was a long, long way to go before it could make a concrete contribution to medical development.


‘It’s most ... most likely use, is the technology of human enhancement’: Chinese scientists alter genes in human embryos in controversial study

One of the fears of scientists and ethicists is the prospect of designer babies. Image: Corbis

*** ONE TIME USE ONLY *** Metalic DNA Molecule. Daily Features, Health, 10FEB2014

****This image has been licensed for one time use only. Please contact the copyright owner BEFORE reusing this image***** 27 Jun 2003 --- Karyotype of a Normal Human Female --- Image by © Visuals Unlimited/Corbis

Britain approves controversial gene-editing technique after Chinese scientists condemned for modifying human embryos  

No Caption Available.

Britain’s granting of its first licence for the genetic modification of human embryos is likely to raise ethical concerns. Photo: Shutterstock

Chinese scientists genetically modify human embryos for the first time

Chinese scientists have successfully edited the human genome for the first time. Photo: SCMP Pictures

The team of genome-editing scientists are based out of Sun Yat-sen University in Guangzhou. Photo: SCMP Pictures

News

China

People & Culture

But researchers say technology should not be applied until ‘thorough evaluation and discussion’ by global research and ethics community
